All aspects of cardiovascular function are regulated by receptors of the seven transmembrane receptor (7TMR or GPCR) families, and they are the commonest target of therapeutic drugs. A universal mechanism regulating these receptors is desensitization of heterotrimeric G protein signaling. Classically, this is mediated by a two- step process in which activated receptors are phosphorylated by G protein-coupled receptor kinases, leading to the binding of a -arrestin (arr) molecule which sterically interdicts further activaion of the G protein. More recently it has become clear that arrs can also serve as multifunctional adaptors which act as signal transducers in their own right. Moreover, many receptors ligands can be found which disproportionately activate either G protein- or arr-mediated signaling - i.e. biased ligands which may possess greater specificity of action and fewer side effects. One such ligand for the angiotensin II type 1 receptor (AT1R) is now in clinical trials for decompensated congestive heart failure. Accordingly this proposal has three closely linked aims which involve developing a molecular- and atomic-level understanding of how such arr-mediated signaling is generated using as model systems two receptors of great cardiovascular significance, the 2- adrenergic receptor and the AT1R. 1) To determine the molecular mechanisms underlying biased agonism at the AT1R utilizing a remarkable panel of both G- and arr-biased AT1R peptide ligands which we have previously characterized. The dynamic biophysical techniques of electron paramagnetic resonance and hydrogen deuterium exchange mass spectrometry will be utilized to reveal the nature of the biased receptor conformations. 2) To determine the molecular mechanisms underlying 7TMR-arr interactions by applying these same techniques to complexes of these two receptors with arr, obtaining information on both receptor and arr conformations. 3) To crystallize and determine the structures of these 7TMR-arr complexes. The insights which we will generate have the potential to guide the design of powerful new cardiovascular drugs and will further our understanding of the conserved signaling mechanisms of the greater 7TMR family.

Public Health Relevance

Some of the most important drugs used to treat cardiovascular disease such as ' blockers' (-adrenergic receptor antagonists) and 'ARBs' (angiotensin receptor blockers) target specific receptors on the outside of cells. Here we seek to understand, at a molecular level, a novel mechanism by which these receptors signal to the inside of cells, laying the basis for next-generation therapeutics for cardiovascular and other diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL016037-43
Application #
8960485
Study Section
Molecular and Integrative Signal Transduction Study Section (MIST)
Program Officer
Wang, Lan-Hsiang
Project Start
1976-09-01
Project End
2019-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
43
Fiscal Year
2015
Total Cost
$478,655
Indirect Cost
$177,614
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Kim, Jihee; Grotegut, Chad A; Wisler, James W et al. (2018) ?-arrestin 1 regulates ?2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility. Skelet Muscle 8:39
Wisler, James W; Rockman, Howard A; Lefkowitz, Robert J (2018) Biased G Protein-Coupled Receptor Signaling: Changing the Paradigm of Drug Discovery. Circulation 137:2315-2317
Ahn, Seungkirl; Pani, Biswaranjan; Kahsai, Alem W et al. (2018) Small-Molecule Positive Allosteric Modulators of the ?2-Adrenoceptor Isolated from DNA-Encoded Libraries. Mol Pharmacol 94:850-861
Staus, Dean P; Wingler, Laura M; Choi, Minjung et al. (2018) Sortase ligation enables homogeneous GPCR phosphorylation to reveal diversity in ?-arrestin coupling. Proc Natl Acad Sci U S A 115:3834-3839
Smith, Jeffrey S; Lefkowitz, Robert J; Rajagopal, Sudarshan (2018) Biased signalling: from simple switches to allosteric microprocessors. Nat Rev Drug Discov 17:243-260
Ahn, Seungkirl; Kahsai, Alem W; Pani, Biswaranjan et al. (2017) Allosteric ""beta-blocker"" isolated from a DNA-encoded small molecule library. Proc Natl Acad Sci U S A 114:1708-1713
Paek, Jaeho; Kalocsay, Marian; Staus, Dean P et al. (2017) Multidimensional Tracking of GPCR Signaling via Peroxidase-Catalyzed Proximity Labeling. Cell 169:338-349.e11
Liu, Xiangyu; Ahn, Seungkirl; Kahsai, Alem W et al. (2017) Mechanism of intracellular allosteric ?2AR antagonist revealed by X-ray crystal structure. Nature 548:480-484
Stoppel, Laura J; Auerbach, Benjamin D; Senter, Rebecca K et al. (2017) ?-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X. Cell Rep 18:2807-2814
Cahill 3rd, Thomas J; Thomsen, Alex R B; Tarrasch, Jeffrey T et al. (2017) Distinct conformations of GPCR-?-arrestin complexes mediate desensitization, signaling, and endocytosis. Proc Natl Acad Sci U S A 114:2562-2567

Showing the most recent 10 out of 302 publications